A REVIEW OF OZEMPIC’S OFF LABEL USE FOR WEIGHT LOSS IN NON-DIABETIC INDIVIDUALS: CLINICAL EVIDENCE, SAFETY AND ETHICS. Biosci. Insights. [Internet]. 2026 Oct. 2 [cited 2026 Nov. 13];3(3):48-53. Available from: https://www.biosciinsights.com/index.php/BI/article/view/188